reLink Medical

relinkmedical.com

reLink Medical
reLink Medical is the nation’s largest independent provider of medical equipment disposition services. Experiencing rapid growth and success, we’re also building a company culture that empowers

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights, PHARMA TECH

CAMBREX ANNOUNCES THE ACQUISITION OF SNAPDRAGON CHEMISTRY

Cambrex | January 24, 2023

news image

Cambrex, a renowned global contract development and manufacturing organization (CDMO) offering drug substance, product, and analytical services throughout the drug lifecycle, recently announced the completion of its acquisition of Snapdragon Chemistry, a US-based provider of chemical process development services to a diverse range of emerging and established biopharma customers. Snapdragon Chemistry specializes in the development of active pharmaceutical ingredient (API) batch a...

Read More

Pharmacy Market

LIDDS NEXT STEP WITH NANOZOLID® FORMULATED DOCETAXEL

LIDDS AB | February 22, 2022

news image

LIDDS AB announced that the next step in the development of NanoZolid®-formulated docetaxel will be to conduct a short clinical study to understand the immunological effects observed in the Phase I clinical study NZ-DTX-001. In the NZ DTX-001 study, activation of systemic inflammatory biomarkers was observed, which can provide improved conditions for treatment with so-called checkpoint inhibitors and result in treatment effect in non-injected tumors. In the clinical phase I st...

Read More

OXYCONTIN MAKER PURDUE PHARMA STARTS AD CAMPAIGN FOR CLAIMS

MSN | February 25, 2020

news image

OxyContin maker Purdue Pharma launched an ad campaign Monday to tell people harmed by their powerful prescription opioid where they can file claims against the company. The $23.8 million campaign is part of Purdue's bankruptcy proceedings as it tries to resolve close to 3,000 lawsuits over its role in the opioid crisis. Notifying people who may have claims against a company is a standard part of a bankruptcy case. But Purdue’s efforts —worked out with input from a committee of cr...

Read More

Pharmacy Market

VERIX ACQUIRES START-UP.AI, FURTHER ENHANCING ITS CAPABILITIES TO LEVERAGE THE POWER OF AI TO ACCELERATE BRAND GROWTH FOR LIFE SCIENCE COMPANIES

PRNewswire | June 16, 2023

news image

Verix, the leading provider of Tovana, an AI driven commercial optimization platform for the pharmaceutical industry, announced that it has acquired start-up.ai, a team of AI specialists that helps businesses improve their processes using artificial intelligence and machine learning. The start-up.ai team will be fully integrated into Verix's AI lab, with Shahar Cohen, start-up.ai's co-founder and CEO, to serve as Verix's CTO. Pharmaceutical companies currently often ...

Read More
news image

Business Insights, PHARMA TECH

CAMBREX ANNOUNCES THE ACQUISITION OF SNAPDRAGON CHEMISTRY

Cambrex | January 24, 2023

Cambrex, a renowned global contract development and manufacturing organization (CDMO) offering drug substance, product, and analytical services throughout the drug lifecycle, recently announced the completion of its acquisition of Snapdragon Chemistry, a US-based provider of chemical process development services to a diverse range of emerging and established biopharma customers. Snapdragon Chemistry specializes in the development of active pharmaceutical ingredient (API) batch a...

Read More
news image

Pharmacy Market

LIDDS NEXT STEP WITH NANOZOLID® FORMULATED DOCETAXEL

LIDDS AB | February 22, 2022

LIDDS AB announced that the next step in the development of NanoZolid®-formulated docetaxel will be to conduct a short clinical study to understand the immunological effects observed in the Phase I clinical study NZ-DTX-001. In the NZ DTX-001 study, activation of systemic inflammatory biomarkers was observed, which can provide improved conditions for treatment with so-called checkpoint inhibitors and result in treatment effect in non-injected tumors. In the clinical phase I st...

Read More
news image

OXYCONTIN MAKER PURDUE PHARMA STARTS AD CAMPAIGN FOR CLAIMS

MSN | February 25, 2020

OxyContin maker Purdue Pharma launched an ad campaign Monday to tell people harmed by their powerful prescription opioid where they can file claims against the company. The $23.8 million campaign is part of Purdue's bankruptcy proceedings as it tries to resolve close to 3,000 lawsuits over its role in the opioid crisis. Notifying people who may have claims against a company is a standard part of a bankruptcy case. But Purdue’s efforts —worked out with input from a committee of cr...

Read More
news image

Pharmacy Market

VERIX ACQUIRES START-UP.AI, FURTHER ENHANCING ITS CAPABILITIES TO LEVERAGE THE POWER OF AI TO ACCELERATE BRAND GROWTH FOR LIFE SCIENCE COMPANIES

PRNewswire | June 16, 2023

Verix, the leading provider of Tovana, an AI driven commercial optimization platform for the pharmaceutical industry, announced that it has acquired start-up.ai, a team of AI specialists that helps businesses improve their processes using artificial intelligence and machine learning. The start-up.ai team will be fully integrated into Verix's AI lab, with Shahar Cohen, start-up.ai's co-founder and CEO, to serve as Verix's CTO. Pharmaceutical companies currently often ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us